Alison M. Bendele

Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis.

J. Frazier, C. Edwards, A. Bendele, 2000, Arthritis and rheumatism.